Abstract:Objective: To detect the Prognostic significance of apoptosis pathway proteins MCL1 and FBW7 in patients with advanced non small cell lung cancer.Methods: Consecutive patients with pathological stage Ⅲ and Ⅳ squamous cell carcinoma(SCC) or adenocarcinoma(ADC) were enrolled retrospectively from Xijing Hospital.Patients who received multidisciplinary treatment modalities and standard supportive care between March 2008 and June 2012 were qualified for this study.We used IHC analysis to determine the expression levels of MCL1 and FBW7 protein in specimens of advanced non-small-cell lung cancer.Patient cumulative survival was analyzed by the Kaplan-Meier method and cumulative survival differences were determined by log-rank test and a Cox regression model adjusted for clinical and pathological factors.Results: The 144 patients,including 64 cases of squamous cell carcinoma,69 cases of adenocarcinoma and 11 other cases.The pathological TNM stages of the patients were stage Ⅲ(45 patients,31.25%) and stage Ⅳ(99 patients,68.75%).Sixty-four(44.44%) patients were observed with high expression levels of Mcl1 and 80(55.56%) with low expression levels of Mcl1.The univariate analysis by log-rank test showed that pathological TNM stage was a significant prognostic factor.The 1-year survival rates of patients were 74.20% for stage Ⅲ(median survival days: 666) and 55.60% for stage Ⅳ(median survival days: 415)(P=0.033).The univariate analysis by log-rank test showed that Mcl1 expression had prognostic significance(P=0.042) while Fbw7 expression had no difference in patient survival(P=0.094).The survival rate of patients at the first year were 69.90% for Mcl1 high expression(median survival days: 612) and 55.30% for Mcl1 low expression(median survival days: 406);there was significant statistically difference(P=0.042).The Cox regression analysis showed that both the expression of Mcl1(HR=1.738,95% CI(1.084-2.787),P=0.008) and pathological TNM stage(HR=0.57,95%CI(0.334-0.973),P=0.039) were independent prognostic factors.Conclusions: This study indicates that Mcl1 protein and Pathological TNM stage both independent prognostic factor for advanced NSCLC.High expression Mcl1 tumors appear to correlate with better prognosis than low expression MCL1 tumors in advanced NSCLC patients.The patients of stage Ⅲ had a better prognosis than those of stage Ⅳ.

NCAPH is Negatively Associated with Mcl‑1 in Non‑small Cell Lung Cancer

Elevated Expression of Mcl-1 Inhibits Apoptosis and Predicts Poor Prognosis in Patients with Surgically Resected Non-Small Cell Lung Cancer

Overexpression of HSP10 correlates with HSP60 and Mcl-1 levels and predicts poor prognosis in non-small cell lung cancer patients

Non-SMC Condensin I Complex Subunit H (NCAPH), a Regulator of Cell Cycle, Predicts Poor Prognosis in Lung Adenocarcinoma Patients: a Study Mainly Based on TCGA and GEO Database

Myeloid Cell Leukemia-1 is an Important Predictor of Survival and Progression of Small Cell Lung Cancer

NCAPH is a prognostic biomarker and associated with immune infiltrates in lung adenocarcinoma

Prognostic Significance Of Mcl-1 In Advanced Non-Small Cell Lung Cancer Patients

High expression of Cullin1 indicates poor prognosis for NSCLC patients.

Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis

Loss of LIMCH1 Predicts Poor Prognosis in Patients with Surgically Resected Lung Adenocarcinoma: A Study Based on Immunohistochemical Analysis and Bioinformatics

CXCL1 As an Unfavorable Prognosis Factor Negatively Regulated by DACH1 in Non-small Cell Lung Cancer

An Integrative Pan-Cancer Analysis Reveals the Carcinogenic Effects of NCAPH in Human Cancer.

FOXM1/lncRNA TYMSOS/miR-214-3p–Mediated High Expression of NCAPG Correlates With Poor Prognosis and Cell Proliferation in Non–Small Cell Lung Carcinoma

MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer

Non‐SMC condensin I complex subunit H participates in anti‐programmed cell death‐1 resistance of clear cell renal cell carcinomas

Overexpression of CHD1L is Positively Associated with Metastasis of Lung Adenocarcinoma and Predicts Patients Poor Survival

MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance

Expression of Monocyte Chemoattractant Protein-1 and CC Chemokine Receptor 2 in Non-Small Cell Lung Cancer and Its Significance

NCAPH Plays Important Roles in Human Colon Cancer

Revisiting the role of MCL1 in tumorigenesis of solid cancer: gene expression correlates with antiproliferative phenotype in breast cancer cells and its functional regulatory variants are associated with reduced cancer susceptibility

[Expression and Clinical Significance of Mcl-1 in T-cell Non-Hodgkin's Lymphoma].